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Abstract
This report examines whether participants in a study of treatments for marijuana dependence may
have increased their use of alcohol when they reduced or ceased marijuana use. Participants were
randomly assigned to one of four psychosocial treatments and followed at 3-month intervals for one-
year. Findings are from 207 cases with data at posttreatment and at least one other follow-up. 73%
of cases reported an increase of at least 10% in drinking days over their level at intake, and 65%
reported an increase of at least 10% in drinks per drinking day. Drinking increases were not related
to treatment condition nor to change in marijuana use, but were related to baseline drinking: those
with less baseline drinking tended to increase their drinking during treatment and those with more
baseline drinking reported less drinking during treatment. Thereafter, drinking levels remained fairly
stable throughout the follow-up year. The results are most likely reflective of a regression to the mean
effect, and indicate that use of alcohol and marijuana are independent of one another.
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1. Introduction
Substance substitution is a potential concern in treating substance use disorders. Clinicians
frequently caution patients about the danger of substituting a ‘safe’ substance (one that has not
been a problem) after they cut down or stop using the one(s) for which they sought treatment.
Researchers have been advised to include multiple dependent measures in assessment batteries
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to assess for the possibility of substance substitution (Jeffrey, 1975). In a recent study of
treatments for marijuana dependence (Kadden et al., 2007), we noted anecdotally that some
participants increased use of alcohol as marijuana use declined.
Two studies of treated marijuana-dependent individuals, and two studies of untreated
marijuana users, reported that reductions in marijuana use were not accompanied by increased
drinking (Hammer & Vaglum, 1992; Hughes et al., 2008; Marijuana Treatment Project
Research Group, 2004; Stephens et al., 2000). However, one study (Copersino et al. 2006)
reported that about one-third of untreated daily marijuana users who quit, increased use of
alcohol.
The present report provides a systematic analysis of the extent to which participants without
current alcohol dependence increased drinking when they reduced or ceased marijuana use
during psychosocial treatment (Kadden et al., 2007).
2. Methods
2.1 Participants
People who wanted help stopping or decreasing marijuana use were recruited through print
and radio advertisements. Participants met DSM-IV criteria for marijuana dependence
(American Psychiatric Association, 1994) and used marijuana on ≥40 of the prior 90 days.
People were excluded if they currently met dependence criteria for other illicit substances or
alcohol, or had severe medical or psychiatric problems that precluded participation. The sample
included 240 participants ≥18 years, average age 32.7 (SD=9.6), 29% female, 38% non-
Caucasian, 60% unmarried, and 37% unemployed. This paper is based on 207 cases with data
at posttreatment and at least one other follow-up.
Participants provided IRB-approved informed consent, and were randomly assigned among
four conditions: (1) two sessions of Motivational Enhancement Therapy plus seven of
Cognitive Behavior Therapy (MET/CBT); (2) contingency management (ContM), with
vouchers provided for drug-free urines; (3) MET/CBT plus ContM; or (4) case management
(CaseM). All interventions were provided in nine individual sessions with a therapist, for 1
hour each, or with a research assistant for 20 minutes (ContM). The MET/CBT and CaseM
interventions were similar to those in the Marijuana Treatment Project (Marijuana Treatment
Project Research Group, 2004). ContM was similar to that described by Petry et al. (2005).
2.2 Measures
The Time-Line Follow-Back (TLFB) was used to gather marijuana frequency-of-use data
during the 90 days before intake and each follow-up (Sobell & Sobell, 1992). Alcohol use was
assessed by point estimates of number of days of use, average quantity per day, and days of
heavy drinking over the preceding 90 days. Additional assessments included the Addiction
Severity Index (ASI; McLellan et al., 1992), Beck Depression Inventory (Beck et al., 1979),
Marijuana Problem Scale (Stephens et al., 1993), Coping Strategies Scale (Litt et al., 2003),
and a measure of self-efficacy (Stephens et al., 1995). Assessments were conducted at study
intake, posttreatment (approximately 2 months later), and at 3-month intervals for 1 year (5,
8, 11, and 14 months post-intake). Further information can be found in Kadden et al. (2007).
2.3 Data Analysis
The two primary drinking variables were frequency, the proportion of days using alcohol
(PDUA) in the previous 90 days, and quantity, drinks per drinking day (DDD). Participants
were considered to have increased drinking if their PDUA or DDD at any follow-up point was
≥10% over baseline. A 10% increase is a small change, given the low levels of baseline
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drinking; it provided a sensitive criterion for detecting change. Logistic regressions evaluated
predictors of increased v. non-increased drinking (PDUA and DDD).
3. Results
3.1 Drinking Frequencies and Quantities
Drinking levels were quite low in this sample. Mean PDUA at intake was .12 (SD=.18), with
33 (16%) cases reporting no drinking, and 139 (67%) reporting drinking <3 days per month.
Mean DDD at intake was 2.8 drinks (SD=2.8), with 178 (86%) reporting no heavy drinking
days. Alcohol dependence was an exclusion criterion, minimizing heavy drinking at intake.
3.2 Occurrence of Increased Drinking
Examination of PDUA indicated that 73% (151 cases) reported an increase in drinking days
of ≥10% over intake at some point after treatment began. Logistic regression indicated that
increased drinking days were not related to treatment condition, but to baseline drinking
frequency. Those with higher frequencies of baseline drinking were less likely to increase
drinking at later time points (B=-3.87; se=1.06; Wald χ2=13.32; p<.001; OR=0.02; 95% CI:.
01-.17). This effect is illustrated in Panel A of Figure 1, which depicts mean drinking frequency
across the trial by drinking change status. Those who did not increase drinking had reported
more frequent drinking at baseline, and actually decreased drinking during treatment [within
group Fpre-post(1,55)=27.32; p<.001]. Conversely, those who drank more frequently after
starting treatment, began with lower levels which increased significantly at posttreatment
[within-group Fpre-post(1, 150)=20.64; p<.001]. Following these initial changes, the average
frequency of drinking remained fairly stable, at an average level of approximately 0.12 (about
3.6 days/month) across all participants throughout the follow-up year.
Results were similar for DDD: 65% (135 cases) increased DDD ≥10% after starting treatment.
As with PDUA, treatment condition was not a factor in who increased drinking, but
pretreatment drinking intensity was (B=-0.22; se=0.06; Wald χ2=12.12; p<.001; OR=0.80;
95% CI:.71-.91). Those with higher baseline DDD were less likely to report increases in DDD
after starting treatment (Figure 1, Panel B), and this remained relatively stable throughout
follow-up.
An initial impression is that changes in drinking during treatment might be characterized as a
regression to the mean effect (Finney, 2007), in which the distribution narrows over time. Due
to the absence of a treatment condition effect on drinking, treatment was not considered in any
subsequent analyses.
3.3 Effects of Reduced Marijuana Use on Increased Drinking
Marijuana use (proportion days of use, PDUM) decreased sharply from pre to posttreatment
in all conditions, and remained at a relatively low level through the 14-month follow-up
(Kadden et al., 2007). A marijuana use change score was computed (intake PDUM minus
posttreatment PDUM) to represent the reduction for each person.
With PDUA increase as the criterion, and marijuana change score and intake PDUA as
predictors in a logistic regression analysis, significant effects occurred only for intake PDUA
(B=-3.83; se=1.04; Wald χ2=13.58; p<.001; OR=0.02; 95% CI:.01-.16). The marijuana change
score failed to show an effect on drinking. Similarly, when drinking was defined in terms of
DDD, marijuana change score had no effect but baseline DDD was a significant predictor
(B=-0.21; se=0.06; Wald χ2=11.82; p<.001; OR=0.80; 95% CI:.71-.91).
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For illustrative purposes, participants were classified into three drinking groups, based on
frequency tertiles of PDUA at intake: 34% were classified as low drinkers (intake PDUA=.
00–.03), 33% as mid drinkers (PDU=.03–.11), and 33% as high drinkers (PDUA≥. 11). Figure
1, panel C, shows the relationship between marijuana use and drinking rates (PDUA) over
time, for the three levels of initial drinking. Frequency of marijuana use did not differ among
drinking levels: light, mid, and heavy drinkers all smoked at equal rates, and reduced smoking
by equivalent amounts. Panel C also shows that drinking did not increase as marijuana use
decreased, suggesting that participants did not compensate for decreased marijuana use by
increasing drinking.
3.4 Determining Increased Drinking
It appears that reduced marijuana use was not a factor in the increased drinking that occurred.
Logistic regressions assessed if increased drinking could be explained by other variables. For
the first analysis, PDUA increase of ≥10% was the criterion variable. Predictors included
demographics (age, sex, ethnic group, education, employment, and marital status), psychiatric
status indicators, substance use severity, and measures of coping and self-efficacy for changing
marijuana use. With these variables in the model the only significant predictor of increase in
PDUA was baseline drinking (B=-4.36; se=1.21; Wald χ2=13.05; p<.001; OR=0.01; 95% CI:.
01-.14).
The same set of variables was used to predict a DDD increase of ≥10%. The only significant
predictors were baseline coping score and baseline DDD. As seen previously, those with higher
baseline drinking were less likely to increase drinking over the study period. (B=-0.30; se=0.08;
Wald χ2=13.58; p<.001; OR=0.74; 95% CI:.63-.87). Additionally, those with higher coping
scores were less likely to drink above baseline levels (B=-1.01; se=0.40; Wald χ2=6.26; p<.
05; OR=0.37; 95% CI:.17-.80).
3.5 Progression to Dangerous Drinking
To evaluate the possibility that reduction of marijuana use might prompt drinking at dangerous
levels, we examined the rate of heavy drinking days. At each follow-up, participants were asked
how many times they consumed ≥6 drinks a day. Response options were: (0) never; (1)
<weekly; (2) weekly (1-1.9 times/week); (3) <daily (2-4 times); and (4) daily or almost daily
(5-7 times).
The median value of the Heavy Drinking Days variable was 0 at all time points, and the mean
was below 0.55 (between ‘never’ and ‘<weekly’). Correlations of marijuana use with the heavy
drinking frequency categories were non-significant. Thus, dangerous drinking in response to
reduction or cessation of marijuana use did not occur in this study.
4. Discussion
On average, participants cut their marijuana use at least in half. At the same time, a considerable
number (73%) increased their drinking by at least a small amount. Nevertheless, there was no
relationship between drinking and change in marijuana use. The only variable consistently
related to increased drinking was a low level of baseline drinking.
We utilized a very liberal criterion for detecting increased drinking. A change of 10% above
baseline represents an increase of only 1.08 in number of days out of 90 on which drinking
occurred, and an increase of only 0.28 drinks per drinking day. Although 73% of cases
increased PDUA and 65% increased DDD, these upward shifts were quite small, as seen in
Figure 1. None of the analyses provided any indication that these shifts were related to changes
in marijuana use, treatment type, or any other predictor variables tested, leaving us unable to
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account for the shifts. One may conclude that reduced marijuana use does not substantially
enhance drinking in a non alcohol-dependent sample. It would nevertheless be prudent in
clinical settings to monitor drinking to detect cases that do increase.
In this study there appeared to be a regression to the mean effect, with heavier drinkers at
baseline reducing drinking at the follow-ups, and lighter drinkers showing an increase. The
reason for this is unknown. The extent to which it may have involved a change in participants'
reporting of drinking across the trial cannot be determined.
There was an inverse relationship between total coping score and the DDD measure:
participants with higher coping scores were less likely to increase drinking. Although this
makes intuitive sense, it is an isolated finding that cannot be given too much credence.
Some limitations ought to be noted. Because the underlying study was an evaluation of
treatments for marijuana dependence, drinking data were not collected with the same precision
as marijuana data. Whereas the TLFB was used to assess daily marijuana use, drinking was
estimated as an average over the preceding 90 days, which is less accurate than the daily
assessment procedure, and there was no verification of drinking self-reports. Finally, to focus
the study on marijuana dependence, people who were also dependent on alcohol or other drugs
were excluded, thereby limiting the upper range of drinking.
We are left with a mystery: 73% of participants increased their PDUA slightly in this study of
marijuana treatment, but there were no indications that this was due to treatment, decreased
marijuana use, or other variables. These results most likely reflect regression to the mean. This
study may help allay concerns of treatment providers, in that treatment will likely not result in
increased drinking in non alcohol-dependent individuals.
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Panels A and B: mean drinking during the 90 days preceding baseline and each of the five
follow-up points, subdivided according to those who increased their drinking above the level
recorded at intake, and those who did not increase their drinking. Panel A: drinking frequency
data; Panel B: drinking quantity per drinking day. Panel C: frequency of alcohol and marijuana
use across the trial, subdivided into three groups based on level of drinking during the 90 days
prior to intake: least drinking prior to intake; moderate level of drinking; and highest level of
drinking.
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